Short Information | Synthetic Biologics Inc. (NYSE:SYN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 27,578 |
Total Actual Volume | 977,413 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,379 |
Average Short Percentage | 2.61% |
Is there a SYN Short Squeeze or Breakout about to happen?
See the SYN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
10-12-2022 | $1.02 | $1.02 | $1.02 | $0.97 | 57,189 | 15,904 | 27.81% |
10-11-2022 | $1.01 | $1.01 | $1.045 | $1.01 | 27,473 | 180 | 0.66% |
10-10-2022 | $1.11 | $1.03 | $1.11 | $1.03 | 12,291 | 57 | 0.46% |
10-07-2022 | $1.14 | $1.06 | $1.14 | $1.06 | 24,824 | 511 | 2.06% |
10-06-2022 | $1.16 | $1.14 | $1.19 | $1.13 | 35,890 | 438 | 1.22% |
10-05-2022 | $1.08 | $1.15 | $1.16 | $1.07 | 36,527 | 59 | 0.16% |
10-04-2022 | $1 | $1.04 | $1.06 | $1 | 66,143 | 1 | 0% |
10-03-2022 | $1 | $1.0201 | $1.05 | $1 | 79,248 | 847 | 1.07% |
09-30-2022 | $1.05 | $0.986 | $1.05 | $0.97 | 75,142 | 100 | 0.13% |
09-29-2022 | $1.06 | $1.06 | $1.06 | $1.04 | 22,936 | 111 | 0.48% |
09-28-2022 | $1.04 | $1.07 | $1.09 | $1.035 | 25,116 | 278 | 1.11% |
09-27-2022 | $1.08 | $1.05 | $1.11 | $1.036 | 40,448 | 1,540 | 3.81% |
09-26-2022 | $1.04 | $1.04 | $1.06 | $1.03 | 40,177 | 19 | 0.05% |
09-23-2022 | $1.12 | $1.06 | $1.13 | $1.05 | 33,145 | 1,358 | 4.1% |
09-22-2022 | $1.11 | $1.11 | $1.15 | $1.0801 | 68,318 | 375 | 0.55% |
09-21-2022 | $1.2 | $1.16 | $1.2 | $1.11 | 114,025 | 1,578 | 1.38% |
09-20-2022 | $1.28 | $1.21 | $1.29 | $1.2 | 79,697 | 1,809 | 2.27% |
09-19-2022 | $1.31 | $1.29 | $1.33 | $1.2801 | 31,510 | 527 | 1.67% |
09-16-2022 | $1.34 | $1.34 | $1.3683 | $1.3 | 49,378 | 64 | 0.13% |
09-15-2022 | $1.36 | $1.38 | $1.4 | $1.35 | 57,936 | 1,822 | 3.14% |
News, Short Squeeze, Breakout and More Instantly...
Synthetic Biologics Inc. Company Name:
SYN Stock Symbol:
NYSE Market:
Synthetic Biologics Inc. Website:
ROCKVILLE, Md., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Theriva Biologics, Inc. (NYSE American: TOVX), (“Theriva” or the “Company”) is the new name of Synthetic Biologics, Inc. (NYSE American: SYN). The new name, logo and branding elements were introduced to better ref...
ROCKVILLE, Md., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced the presentation of new data from collaborators at Fund...
- The DSMC has reviewed the safety and pharmacokinetic data from Cohort 1 and recommended that the study may proceed to enroll patients into Cohort 2 - ROCKVILLE, Md., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical...